AAM
SCMP

Alpine Associates Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Alpine Associates Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,495,600
Closed -$26.8M – 65
2017
Q4 		$26.8M Buy
+1,495,600
New +$18.4M 0.96% 26

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alpine Associates Management's SCMP Position: Q1 2018 in Review

Alpine Associates Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 1,495,600 shares — an estimated $26.8M sold.

Alpine Associates Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $26.8M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Alpine Associates Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Alpine Associates Management sold 1,495,600 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $26.8M.
  • Alpine Associates Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Alpine Associates Management's Sucampo Pharmaceuticals, Inc. position peaked at $26.8M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Alpine Associates Management's 13F filing for Q1 2018, filed 11 May 2018.